Lignans and breast cancer risk in pre- and post-menopausal women: Meta-analyses of observational studies

British Journal of Cancer

Volumn 100, Issue 9, 2009, Pages 1492-1498

  Velentzis, L S ^a   Cantwell, M M ^b   Cardwell, C ^b   Keshtgar, M R ^c   Leathem, A J ^a   Woodside, J V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer risk; Enterolignans; Plant lignans

Indexed keywords

ENTEROLACTONE; LIGNAN; LIGNAN DERIVATIVE;

ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER RISK; DIETARY INTAKE; DISEASE ASSOCIATION; EXPOSURE; HUMAN; OBSERVATIONAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIET; FEMALE; META ANALYSIS; RISK; RISK ASSESSMENT; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; DIET; FEMALE; HUMANS; LIGNANS; ODDS RATIO; POSTMENOPAUSE; PREMENOPAUSE; RISK ASSESSMENT; RISK FACTORS;

EID: 65549145792     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605003     Document Type: Article

References (63)

1. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sei 44: 483-525
2. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena PJ, Kellis Jr JT, Vickery LE (1993) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44: 147-153
3. Adlercreutz H, Hämäläinen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT (1989) Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 49: 433-442
4. Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Hämäläinen E, Wähälä K, Mäkelä T, Hase T (1992) Dietary phytoestrogens and cancer: in vitro and in vivo studies. / Steroid Biochem MoI Biol 41: 331-337
5. Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427
6. Bergman Jungeström M, Thompson LU, Dabrosin C (2007) Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13: 1061-1067
7. Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A (2003) Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40: 84-89
8. Bougnoux P, Chajes V (2003) «-Linoleic acid and cancer. In: Flaxseed in Human Nutrition Thompson LU, Cunnane SC (eds), pp 232-244. AOCS Press: Illinois, USA
9. Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem MoI Biol 94: 461-467
10. Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU (2008) Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control 19: 259-272
11. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11: 815-821
12. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH (2001) Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 223-228
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials7: 177-188
14. dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, McMichael AJ, Sevak L (2004) Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 15: 805-818
15. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634
16. Fink BN, Steck SE, Wolff MS, Britton JA, Rabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165: 514-523
17. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 13: 698-708
18. Hankinson SE, Eliassen AH (2007) Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem MoI Biol 106: 24-30
19. Hausner H, Johnsen NF, Hallund J, Tetens I (2004) A single measurement is inadequate to estimate enterolactone levels in Danish postmenopausal women due to large intraindividual variation. J Nutr 134: 1197-1200
20. Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E (2008) Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138: 938-945
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560
22. Horner NK, Kristal AR, Prunty J, Skor HE, Potter JD, Lampe JW (2002) Dietary determinants of plasma enterolactone. Cancer Epidemiol Biomarkers Prev 11: 121-126
23. Horn-Ross PL, Barnes S, Kirk M, Coward L, Parsonnet J, Hiatt RA (1997) Urinary phytoestrogen levels in young women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 6: 339-345
24. Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, Bernstei CL, Deapen D, Peel D, Pinder R, Reynolds P, Ross RK, Wright W, Ziogas A (2002) Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13: 407-415
25. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ (2001) Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am JEpidemiol 154: 434-441
26. Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G (2002) An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 41: 168-176
27. Ingram D, Sanders K, Kolybaba M, Lopez D (1997) Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994
28. Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH (2004) Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79: 282-288
29. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H (2002) Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155: 472-477
30. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, Adlercreutz H (2001) Determinants of serum enterolactone concentration. AmJ Clin Nutr 73: 1094-1100
31. Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, Pietinen P (2004) Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108: 277-280
32. Kuijsten A, Arts IC, van't Veer P, Hollman PC (2005) The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed. J Nutr 135: 2812-2816
33. Kuiper GG, Lemmen JG, Carlsson B, Corto´n JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263
34. Linseisen J, Piller R, Hermann S, Chang-Claude J (2004) Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 110: 284-290
35. Low YL, Dunning AM, Dowsett M, Folkerd E, Doody D, Taylor J, Bhaniani A, Luben R, Khaw KT, Wareham NJ, Bingham SA (2007) Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESRl and NRl 12 gene variants. Cancer Epidemiol Biomarkers Prev 16:1009-1016
36. Mazur W (1998a) Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12: 729-742
37. Mazur WM, Wähälä K, Rasku S, Salakka A, Hase T, Adlercreutz H (1998b) Lignan and isoflavonoid concentrations in tea and coffee. Br J Nutr 79: 37-45
38. McCann SE, Kulkami S, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL (2006) Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 99: 309-311
39. McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG (2002) The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 132: 3036-3041
40. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL (2004) Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 111: 440-443
41. Milder IE, Kuijsten A, Arts IC, Feskens EJ, Kampman E, Hollman PC, Van't Veer P (2007) Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population. J Nutr 137: 1266-1271
42. Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sei 80: 14-25
43. Nesbitt PD, Lam Y, Thompson LU (1999) Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69: 549-555
44. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Moller S, Tjonneland A (2004) Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 13: 2084-2089
45. Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H (2001) Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10: 339 - 344
46. Piller R, Chang-Claude J, Linseisen J (2006a) Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 15:225-232
47. Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J (2006b) CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans. J Nutr 136:1596 -1603
48. Prasad K (2000) Antioxidant Activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int] Angiol 9: 220-225
49. Saarinen NM, Wärri A, Airio M, Smeds A, Mäkelä S (2007) Role of dietary lignans in the reduction of breast cancer risk. MoI Nutr Food Res 51: 857-866
50. Setchell KD, Lawson AM, Bordello SP, Harkness R, Gordon H, Morgan DM, Kirk DN, Adlercreatz H, Anderson LC, Axelson M (1981) Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 2: 4-7
51. Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, WoIk A (2008) Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 98: 636-640
52. Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17:1253-1261
53. Thompson LU (2003) Flaxseed, lignans and cancer. In Flaxseed in Human Nutrition, Thompson LU, Cunnane SC (eds), pp 194-222. AOCS Press: Illinois, USA
54. Thompson LU, Rickard SW, Cheung F, Kenaschuk EO, Obermeyer WR (1997) Variability in anticancer lignan levels in flaxseed. Nutr Cancer 27: 26-30
55. Thompson LU, Robb P, Serraino M, Cheung F (1991) Mammalian lignan production from various foods. Nutr Cancer 16: 43-52
56. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, Lopez-Carrillo L (2008) Dietary consumption of phytochemicals and breast cancer risk in Mexican women. Public Health Nutr 23: 1-7
57. Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F (2007) Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99: 475 -486
58. Touillaud MS, Thiébaut AC, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F (2006) No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidemiol Biomarkers Prev 15: 2574-2576
59. Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters FH (2007) Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 25: 648-655
60. Wang C, Mäkelä T, Hase T, Adlercreutz H, Kurzer MS (1994) Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem MoI Biol 50: 205- 212
61. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S, European Prospective into Cancer-Norfolk cohort (2008) Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res 10: R32. In press
62. Wu AH, Yu MC, Tseng CC, Pike MC (2008) Epidemiology of soy exposures and breast cancer risk. BrJ Cancer 98: 9-14
63. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, Toniolo P (2004) Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 91: 99-105